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III. Acne 
PREV ALENCE AND SEVERITY 
Effect on the Quality of Life 
Acne vulgaris, the most common disease of the skin, affects 
in various degrees more than 80% of the population, usually 
dUJ'ing the second and third decades of life. Clinically significant 
acne, as determined by dermatologists, affects approximately 
20% to 25% of the population between the ages of 12 and 25. It 
begins at or about puberty, a time in life when the child is 
emerging into adulthood and seeking an identity. This normally 
difficult transition period is further aggravated by the additional 
burden of a disease that is, at the least, unattractive and, at the 
worst, severely disfiguring. Acne may persist beyond the age of 
25, particularly in women, and in those who have the severe, 
destructive acne conglobata. 
According to data from a recent national health sUJ'vey, 68.1% 
(15.5 million) of the population between the ages of 12 and 17 
have facial acne. An additional 0.7% (0.2 million) have acne 
affecting other areas of the body. These figures are averages for 
the entire age group (12-17). The data from the 17-year-old 
group alone show that 86.4% have facial acne. The disease, in 
all forms, may persist well into the fOUJ'th decade of life, and 
severe cystic acne occurs in more than 5 persons per thousand 
in the age group 18-34 years. 
Acne tends to be more severe among boys than girls. Nearly 
one-half (49%) of boys examined had moderate-to-severe facial 
acne; about one-third (34%) of girls. Again, the prevalence 
increases with age. Only 12% of 12-year-old boys had moderate 
to severe facial acne; 62% of 17 -year-old boys were so affected. 
All forms of the disease can benefit from treatment. Many 
persons with severe acne do not see a physician because (a) 
they have been led to believe that no satisfactory treatment is 
available; (b) they rely on one of the many over-the-counter 
nostrums; or (c) they cannot afford adequate treatment. On the 
other hand, every dermatologist has probably seen seriously 
concerned patients with very mild acne. One cannot make light 
of mild acne nor consider the problem to be trivial if it is a 
burden to the patient. Between these two extremes lies a 
spectrum of patients with active disease who are variably 
affected. 
Thus, the impact of both mild and severe disease upon the 
quality of life can be significant. The severe forms of papulo-
pustular, nodulocystic, and conglobate acne are painful and 
disfiguring. They may produce significant emotional stress and 
withdrawal leading to neurotic excoriations and a variety of 
desperate measures. 
Economic costs. The economic impact of the disease is diffi-
cult to determine because of an imprecise data base. It is 
estimated that over $100 million is spent annually in the U.S. 
on over-the-counter acne medications, and this figure does not 
include the variety of products sold as soaps and cosmetics 
promoted for adjunctive use. Prescription sales of topical med-
ication for acne are estimated at $18-24 million and do not 
include sales of antibiotics and other drugs. Acne accounts for 
14% of all patient visits to physicians for skin care and 27.5% of 
all visits to dermatologists. This amounts to 9.5 million visits 
per year and does not include visits for treatment of acne 
scarring. In addition, there is an uncalculated economic impact 
in time lost from school and work. Patients with severe nodu-
locystic and conglobated acne may, at times, be incapacitated 
by the painful . draining lesions. A photographic model, for 
example, may suffer a significant loss of income for each day 
that a papule is present on her face. 
Table I, based on most recently available data, summarizes 
the current estimated annual cost of acne in the United States. 
These figures are likely to increase, particularly when one 
considers that more expensive products appear to be gaining 
larger shares of both the prescription and over-the-counter 
markets. 
PREVENTION, TREATMENT, AND CURE 
Today, acne is treatable, but neither cUJ'able nor preventable. 
A realistic assessment of prospects suggests no cUJ'e forthcoming 
in the foreseeable future . More than 75% of the population 
affected with acne can be treated effectively; the current ther-
apeutic armamentarium, properly used, can achieve a reduction 
of 50% or more in the number of lesions present. It is obvious 
that this rate is not satisfactory. Most medications available 
have some unpleasant side effects. Visible improvement can 
usually be attained even in the most severe case; however, 
treatment is long and costly. Most of the effective medications 
are available only through prescription and require supervision 
by a physician. The public is, in general, unaware of the 
availability of such treatment, cannot afford it, or does not 
consider the potential benefit to outweigh the side effects. 
Gastrointestinal distUJ'bances, vaginal moniliasis, and photosen-
sitivity may OCCUJ' with antibiotics. Almost all topical medica-
tions produce undesirable redness and peeling. 
There is no evidence that any treatment regimen prevents 
acne. There is, however, a general belief among clinicians that 
early treatment can reduce the severity of the disease and, in 
some measure, reduce scarring. The data that support this 
general belief are suggestive, but not conclusive. There is a 
10%-15% greater prevalence of moderate-to-severe facial acne 
in girls from low income families (less than $3,000 per year) 
than from families with higher income [2]. There is a decreasing 
trend in the prevalence rates of moderate to severe acne with 
increase in the education level of the parents. Since it appears 
likely that youths from families with higher income and edu-
cation levels will have greater access to adequate dermatologic 
care, this data suggests that treatment does have an impact on 
the overall severity of the disease in the population. 
The prospects for improvement in the treatment are excel-
lent; they depend on support for clinical and basic research and 
on appropriate industrial incentives, particularly to develop 
agents that can be applied topically. Some available drugs 
appear to affect the major factors involved in the pathogenesis 
of the disease, i.e. , sebum production, follicu lar bacterial micro-
flora, follicular epithelial differentiation, and inflammation. The 
development of new drugs that could affect these pathologic 
events depend in great part not only upon advances in basic 
research but also upon the development of better vehicles to 
deliver available drugs more directly to the affected tissues. 
There is reason to believe that the development of derivatives 
of available drugs could be of greater therapeutic benefit. If 
such drugs are developed in the next 2 decades, a measure of 
prevention could be achieved. The expectation of a cure is 
remote if cu.re is defined as a complete reversal of the disease 
process in a short time. 
ST ATUS OF BASIC RESEARCH 
Pathogenesis of Acne 
Our knowledge of the pathogenesis of acne has developed 
principally in the last 2 decades and encompasses several inter-
related areas of research, namely follicular epithelial differen-
tiation, lipids, hormonal influences, microbiology, and inflaJ'!l-
mation. Information that has accrued from study in these areas 
has derived from both basic reseru'ch and clinical investigation. 
Acne occurs with the onset bf puberty. At this time there is 
an increase in androgen production in both boys and girls. 
Androgens directly stimulate the sebaceous glands; they in-
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TABLE I. Total yearly costs 
Outpatient physician fees" 
Prescription dermatological drugs 
Ove r-the-counter drugs" 
" Does not include visits for treatment of acne scarring. 
$190 million 
21 million 
105 million 
b Does not include miscellaneous products such as abradants, 
cle ansers, etc. 
crease in size and increase the production of their holocrine 
product, sebum. Sebum provides a rich nutrient environment 
for the microbial flora of the follicle. In particular, there is a 
proliferation of the anaerobic diththeroid Propionibacterium 
acnes (P. acnes) that produces a series of exoenzymes including 
a lipase that hydrolyzes the triglycerides of sebum to free fatty 
acids. Free fatty acids are potentially comedogenic and may 
play a role in the inflammatory reaction as well. A chemotactic 
factor secreted by P. acnes also appears to be important in the 
early inflammatory process. The end result is an alteration in 
the follicular epithelium. This results in the formation of a 
microcomedo, which is the precursor lesion for the development 
of inflammation. 
Follicular Epithelial Differentiation 
The earliest detectable and pathologic change in acne is an 
alteration in follicular epithelial differentiation. The events 
surrounding this change are poorly understood. Microscopic 
examination of biopsies of acne lesions reveals that acne occurs 
in specialized pilosebaceous follicles, termed sebaceous follicles, 
which possess large sebaceous glands. Cellular kinetic studies 
indicate an increased turnover rate of the epithelial cells of 
these follicles. (It has also been suggested that an alteration 
occurs in the follicular epithelium that renders these cells more 
cohesive, although this has not been substantiated.) The sub-
sequent events are an accumulation of shed follicular cells, 
sebaceous gland secretion (sebum), and bacteria in the follicular 
lumen resulting in the formation of a comedo. Once formed, 
inflammation can develop in the comedo as an inflammatory 
papule, pustule, or nodule . 
Electron microscopic studies have also demonstrated an ac-
cumulation of nonsebaceous lipid within the keratinizing cells 
of the lower portion of the infrainfundibular follicular epithe-
lium. In the normal follicle the keratinous squamae are loosely 
organized; they contain large numbers of lamellar granules and 
few keratohyaline granules. In the early lesions of acne the 
lamellar granules are less numerous and keratohyaline granules 
are larger. The significance of these fmdings in relation to the 
initiation of comedo formation is not understood. 
Lipids 
Considerable progress has been made in our understanding 
of cutaneous lipogenesis specifically relating to sebaceous lipids. 
A substantial body of knowledge exists concerning the specific 
lipids of human and animal skin and the pathways through 
which lipid synthesis occurs in sebaceous glands. 
Studies of regional differences in human skin surface lipid 
composition and analysis of the lipids of isolated human seba-
ceous glands indicate that sebum consists of triglycerides, wax 
esters, squalene, and small amounts of sterols and sterol esters. 
The fatty acids that are synthesized and incorporated into 
esters in the sebaceous gland consist principally of 14-, 16- and 
18-c arbon components with small amounts of shorter and longer 
chain lengths. Almost half of the fatty acids are monounsatu-
rated. These consist almost exclusively of compounds with 
double bands in unusual positions that appear to be derived 
from saturated precursors such as palmitic acid. By chain-
length extension other unsaturated compounds are produced. 
A small proportion of these products apparently undergoes a 
second desaturation resulting in the formation of small amounts 
of dienoic acids. The dienoic acids are apparently also subject 
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to chain extension that produces fatty acids in which the 
unsaturation is 7, 10, 9, 12, or 11, 14. This appears to be the 
mechanism for the formation of linoleic acid, an essential fatty 
acid that cannot otherwise be synthesized in mammalian tissue. 
It is significant because linoleic acid appears to be decreased in 
patients with acne, and the amount of this decrease may cor-
relate with the severity of the disease. 
In addition to unusual patterns of unsaturation, human se-
bum contains a complex mixtw'e of branched chain fatty acids 
that constitute 15% of the saturated acids and a much lower 
proportion of the unsaturated acids. These are all methyl 
branched compounds or series in which a methyl group is 
attached to 1 or 2 even-numbered carbon atoms. 
The lipids of sebum in other mammals differ from man's. 
Triglycerides and squalene, which together constitute approxi-
mately 70% of human sebum, have not been found in significant 
amounts in the sebum of other species. Similarly, the unusual 
patterns of fatty acid unsaturation have not been found in the 
seba of other mammals. These and other differences have 
placed serious constraints on the use of animal models for the 
study of sebaceous gland lipogenesis in relation to acne. 
Regional differences in skin surface lipid composition have 
been ascribed to regional difference in the number of sebaceous 
glands. The principal difference between isolated human seba-
ceous gland lipid and skin surface lipid from areas rich in 
sebaceous glands is the presence of free fatty acids in the latter. 
Data accumulated in numerous experiments suggest that these 
fatty acids derive almost exclusively from the hydrolysis of 
sebum triglycerides. The composition of these free fatty acids 
closely approximate those of triglycerides as opposed to those 
of sterol or wax esters which are more unsaturated and longer 
respectively. Finally, there is an inverse relationship between 
triglycerides and free fatty acids in skin surface lipid, the sum 
of the 2 remaining fairly constant in a given individual. 
The possible role of these free fatty acids in the pathogenesis 
of acne has been the subject of much study. Large quantities of 
free fatty acids injected into skin produce an inflammatory 
reaction, although smaller quantities do not appear to do so. 
Repeated application of free fatty acids to the skin surface 
results in inflammation. In vitro, these same free fatty acids 
appear to be chemotactic to neutrophils and macrophages and 
may also be cytotoxic to these cells. Free fatty acids have been 
shown to be comedogenic in experimental anin1als. When me-
dium length chain free fatty acids are applied to the ears of 
rabbits, comedones are formed. Therefore, free fatty acids are 
thought to play some role in the pathogenesis of acne although 
their effect on follicu lar cell differentiation as well as their 
involvement in the inflammatory process is still poorly under-
stood. 
Hormonal Influences 
The earliest appreciated etiopathogenetic factor in acne was 
hormonal. The recognition of the disease's appearance in pu-
berty and its failure to develop in eunuchs clearly pointed to 
endocrine involvement. In 1940 experiments were described in 
which acne could be induced by the administration of testos-
terone. Studies in both animals and man have shown that this 
is due to sebaceous gland stimulation. 
There is now sufficient data to show that androgens, princi-
pally testosterone, control sebaceous gland size and thus sebum 
production. Experin1ental data from animals and man indicate 
that the sebaceous gland is an androgen target-tissue. Admin-
istration of testosterone in animals and man results in both an 
increase in sebaceous gland size and sebum production. Adrenal 
androgens may also stimulate the sebaceous glands although to 
a considerably lesser degree than testosterone. Thus, both 
dehydroepiandrosterone (DHA) and DHA sulfate have been 
shown to stimulate sebaceous gland secretion. Recent experi-
ments may help to clarify the mechanism' by which adrenal 
androgens stimulate the sebaceous glands. The conversion of 
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DHA to testosterone in human skin in vitro has been demon-
strated. Skin from areas rich in sebaceous glands, such as the 
face, is more active than skin from the thigh where sebaceous 
glands are relatively sparse. It has been postulated that adrenal 
androgens may, therefore, act as prehormo.nes in the skin and 
that steroid-metabolizing enzymes in the sebaceous glands may 
mediate the response of these organs to circulating androgens. 
At the cellular level most androgen target tissues are respon-
sive to dihydrotestosterone (DHT), which is formed intracel-
lularly by the 5 a reduction of testosterone. Numerous studies 
have demonstrated that testosterone is converted to DHT in 
human skin. Since none of these studies has been performed on 
isolated sebaceous glands, one cannot be certain that this 
conversion takes place in human sebaceous glands. Neverthe-
less, studies on isolated sebaceous gland complexes, such as the 
hamster flank organ, have demonstrated 5 a reductase activity 
in these specialized sebaceous organs. 
In other androgen-sensitive tissues DHT combines with a 
receptor protein in the cytoplasm to form a DHT-receptor 
complex. The latter then enters the nucleus to combine with 
chromatin and stimulates RNA synthesis. Recent experiments 
suggest that this process occurs in sebaceous glands as well, 
although experiments with human sebaceous glands are lacking. 
Thus DHT binding protein has been isolated and characterized 
in both the nucleus and cytosol of isolated sebaceous glands 
from the hamster flank organ. Testosterone binding sites have 
also been described, as in other tissues. 
The significance of these processes in relation to acne is 
unclear. Investigations in man suggest increased DHT forma-
tion in acne. Higher conversion of testosterone to DHT has 
been demonstrated in skin biopsy specimens taken from the 
face and back of acne subjects than in the same areas in control 
subjects. This, however, may simply reflect a larger quantity of 
sebaceous tissue in the acne subjects than that in control 
subjects. Similarly, higher urinary excretion of a DHT metab-
olite, 5 a-androstane-3a, 17B-diol has been found in women 
with acne than in women without acne. This may reflect an 
increased metabolism of testosterone at many sites, including 
the skin. 
Finally, there may be 2 distinct actions of androgen on 
sebaceous cells, one stimulating mitoses and the other lipoge-
nesis. This is suggested by studies in which certain androgens 
that stimulated sebaceous cell mitoses did not increase sebum 
production. 
Although the effect of estrogens on sebaceous glands in 
experimental animals and. in man has been well studied, the 
mechanism of action is less clear than it is with androgens. 
Estrogens decrease the size of sebaceous glands and reduce 
sebum production. How they do so at the cellular level is not 
fully understood. Conflicting data center around the observa-
tions that local glandular suppression have been demonstrated 
in animals but not in man. 
The role of progesterone is even less well understood since 
data on experimental animals and human beings are in conflict. 
Progesterone, in large doses, stimulates sebaceous glands of rat 
but not of man. Progesterone is nonandrogenic in man and thus 
not likely to stimulate sebum production. Conversely, some 
investigators even suggest that progesterone may act as an 
antiandrogen by competing with testosterone for 5 a-reductase. 
The role of pituitary hormones in the control of sebaceous 
glands is also unclear. Prolactin, melanocyte-stimulating hor-
mones (MSH), ACTH, and thyroid-stimulating hormone 
(TSH) have a direct or indirect stimulating effect upon rodent 
sebaceous glands; this effect has not been substantiated in 
human beings. However, we know that sebum production is 
increased in patients with parkinsonism, an effect allegedly 
resulting from elevated MSH levels or other hypoth.alamic 
hormones. This is not supported by direct experimental evi-
dence. 
Although cortisol does not have a direct effect upon seba-
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ceous glands, it appears to be required for maximal sebaceous 
gland stimulation by testosterone. On the other.hand, the fact 
that adrenocortical suppressive doses of prednisone decrease 
sebum production in women and eunuchs but not in normal 
men is an indication that there is maximal sebaceous gland 
stimulation by gonadal testosterone in normal men and that 
the adrenals are in addition to the ovary, an important source 
of androgens for sebaceous gland stimulation in women. 
Microbiology 
The pathogenic role of the microbial flora has r.eceived ~uch 
attention in the past decade. Three groups of microorganisms 
co-exist in the normal pilosebaceous follicles of human skin. 
These are: gram positive, coagulase negative cocci (?taphylo-
cocci and Micrococci), anaerobic diptheroids (Propwmbacte-
rium acnes and Propionibacterium granulosum) , and lipophilic 
yeasts (Pityrosporum species). Qualitatively, the microflor~ of 
comedos is similar to that o.f the normal sebaceous follicle . 
Active colonization of the follicle, however, does nat occur until 
mature pilosebaceous follicles develop, a time coincident with 
the development of acne. 
Detailed characterization of the microflora is lacking. Thus, 
although the Staphylococci and Micrococci have been classified 
according to their ability to. ferment a variety o~ sugars ~nd .to 
produce coagulase, little attention has been paid to their bIO-
chemistry and physiology in relation to. acne. Although all 3 
groups of o.rganisms appear to possess lipolyti~ a~tivity, selec-
tive antibiotic inhibition studies indicate that Significant reduc-
tion in free fatty acids occurs only when P. acnes is suppressed. 
Assay of partially purified lipolytic enzymes from these orga-
nisms indicates that true lipase activity is limited to P. acnes; 
the other organisms produce mo.stly a nonspecific esterase. 
Staphylococci rapidly become resistant to antibiotics that re-
duce both P . acnes and free fatty acids. Thus, it appears that 
lipolytic enzymes secreted by P. acnes are primarily respon~ible 
for generating the free fatty acids through the hydro.lysls of 
sebum triglycerides. . . 
Further purification of P. acnes bpase has been achieved 
through column chromato.graphy, ion :x.change chrom~to~a­
phy, and affinity chromatography. AddltlOnal.charac~enzatlOn 
of this lipase suggests that it possesses a terminal senne group 
and is a true lipase (3.1.1.3) capable of hydrolyzing triglycerides 
in a heterogeneous system. It also hydrolyzes mixtures of tri-
glycerides similar to those found in pure sebum. 
P. acnes secretes several other extracellular products that 
may explain its role in the pathogenesis of acne; among these 
are hyaluronidase, proteases, and chemotactic factors for neu-
trophils, lymphocytes, and macro phages. One rep art suggests 
that the lipase is a neutrophil chemotactant; the other chemo-
tactants have not been fully identified. The proteases are nat 
yet well characterized. 
P. acnes and P. granulosum produce porphyrins. These have 
been identified as coproporphyrin III on the basis of absorption 
and fluo.rescence spectra and chromatography. Significantly 
greater amounts of porphyrin are produced by P. granulosum 
than by P. acnes. Although probably not related to the patho-
genesis 'of acne, the characteristic fluorescen~e of these porphy-
rins can be used as a marker to observe relatively large changes 
in the density of these organisms. 
Inflammation 
Our understanding of the events involved in the inflammatory 
process of acne is incomplete. The pathogenesis of the inflam-
matory lesion consists of an early accumulation of neutrophils 
at the follicular wall followed by a dense inftltration of lympho-
cytes and monocytes. The events that lead to rupture of the 
follicular wall are poorly understood. When such rupture occurs, 
a foreign body readion (probably to keratinous material) en-
sues. 
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Recent experiments suggest that P. acnes secretes more than 
one c h emotactic substance t hat may be responsible for some of 
the inflammatory events. As mentioned in the last section, one 
series of experiments has demonstrated t hat P. acnes lipase is 
chemotactic for neutrophils. In these experiments neutrophil 
chemotaxis by P. acnes lipase was independent of serum factors. 
Other studies suggest that a smaller molecular weight protein, 
secreted by P. acnes and similar to that described for E. coli, 
is also chemotactic for neutrophils and is serum dependent. 
Complement activation by P. acnes has also been described; 
kinins and other mediators of inflammation have not. A cell 
derived P. acnes factor, chemotactic primarily for monocytes, 
has recently been described. In the last section we mentioned 
the potential role of free fatty acids in chemotaxis. Of particular 
interest in this regard are the recent observations that broad-
spectrum antibiotics, such as tetracycline and erythromycin, 
are capable of inhibiting neutrophil chemotaxis by P. acnes in 
vitro and inhibit the formation of potassium iodide-induced 
sterile pustules in vivo. 
Finally, although P. acnes is considered to be nonpathogenic 
in the sense that it is noninvasive, intradermal injection of 
suspensions of physiologic numbers of this organism induce 
inflammation, particularly in subjects with acne. It is undeter-
mined whether the inflammatory response induced is depen-
dent on prior sensitization of the host's immune system. 
Immunology 
It has long been known that subjects with inflammatory acne 
develop an immune response to P. acnes. It is manifested by 
elevated serum antibody titers and an increase in the frequency 
and intensity of immediate hypersensitivity reaction to P. acnes 
an tigens. There is correlation between the severity of the in-
flarnrrlatory acne and the antibody titers to P. acnes. The 
relationship of this immune response to the pathogenesis of 
inflammatory acne is undetermined. It could be completely 
unrelated to the disease process; it could merely reflect the 
increased exposure of the host's immune system to P. acnes in 
acne lesions. Alternatively, reactions of serum antibodies and 
lymphocytes sensitized with P. acnes antigens in the dermis 
could intensify the inflammatory response by involvement of 
the complement system and other mediators of inflammation. 
Delayed hypersensitivity, measured by reaction to intrader-
mal injection of common antigens, is decreased in patients with 
severe cystic acne. However, lymphocytes from these subjects 
show a significantly increased blast transformation in response 
to stimulation with P. acnes antigen. 
Other immunological abnormalities have been observed in 
some patients with severe cystic and conglobated acne. Thus, 
some patients appear to have defective neutrophil chemotaxis 
whereas others appear to have specific neutrophil phagocytic 
dysfunction. No significant abnormalities in other immunolog-
ical parameters have been observed. 
Finally, although the significance of the immune response to 
P. acnes in the pathogenesis of acne is unknown, it now appears 
that P. acnes is synonymous with Corynebacterium parvum. 
The immunopotentiation properties of C. parvum are well 
recognized; however, how this relates to acne has not been 
explained. 
Genetics 
Little is known about the genetics of acne. It is widely 
assumed that acne is a polygenic disease with varied expressiv-
ity. T h ere are various claims that the prevalence of the disease 
is lower among orientals and American Indians; however, this 
is not p roven. Comparative epidemiologic studies have not been 
performed, and the prevalence of acne among urban American 
orientals appears to be similar to that of the general population. 
One study reported an association of nodulocystic acne and the 
X¥Y genotype; this has not been confirmed. Finally, although 
ACNE 437 
most males with nodulocystic acne have fathers who were 
similarly affected, significant numbers of these patients have no 
family history of this severe form of the disease. 
STATUS OF CLINICAL RESEARCH 
Acne Vulgaris 
Acne vulgaris is the most common form of the acne disorders 
and consists of open and closed comedones (blackheads and 
whiteheads), papules, pustules, and nodulocystic lesions. Al-
though the disease most commonly affects the face, the chest 
and back are not infrequently involved, particularly in the more 
severe forms of the disease. T he onset of t he disease is usually 
coincident with puberty. In general, more pronounced disease 
is present in older teenagers than in younger ones and the 
disease may persist well into t he third and fourth decades of 
life. On the other hand, it is not uncommon for acne to first 
manifest itself with a few comedones well in advance of puberty. 
CUJTent concepts of the pathogenesis of acne implicate an-
drogen stimulation of the sebaceous glands with a resultant 
increase in sebum production as the initiating pathogenic event. 
With the development of sebaceous follicles laden with sebum 
there is a proliferation of the follicular microflora. Lipolytic 
enzymes secreted by P. acnes hydrolyze sebum triglycerides to 
free fatty acids t hat appear to alter follicular epithelial differ-
entiation so that t here is an increased turnover in the epithelial 
cells. Although the specific events that then lead to comedo 
formation are poorly understood, a role for proteolytic enzymes 
secreted by P. acnes is postulated. Whether or not the other 
follicular microorganisms (staphlococci, micrococci, and pity· 
rosporum) are involved in the pathogenesis of acne is not 
known. 
The inflammatory lesions of acne appear to develop from 
early comedones. Free fatty acids and chemotactic factors elab· 
orated by P. acnes are probably involved. Whether these sub-
stances diffuse through the follicular wall or through mICro-
scopic breaks in the follicle is not known. The role of the 
mediators of inflammation has not been determined. 
Acne Conglobata 
Acne conglobata is a severe, destructive form of acne, char-
acterized by numerous large, fluctuant, nodulocystic lesions, 
draining sinuses, and double comedones. It invariably produces 
scarring, either hypertrophic, atrophic, or a combination of the 
two. This form of the disease may be associated with a more 
complex syndrome that includes hidradenitis suppurativa, per-
ifolliculitis capitis, and pilonidal cysts. As noted previously 
patients with conglobated acne have high antibody titers to P. 
acnes antigen .and are hyporeactive to common intracutaneous 
tests of delayed hypersensitivity. Neurophil dysfunction has 
been observed in a few of these patients. T he mechanism by 
which this pronounced inflammatory reaction and exuberant 
re-epithelialization occurs in t hese individuals is not under-
stood. 
Acne fulminans, or acute febrile ulcerative necrotic acne, is 
a rare, severely tissue-destructive variant of acne. It is accom-
panied by fever, leukocytosis, and neutrophil dysfunction. 
Acne Secondary to Environmental and Physical Factors 
It has long been known that specific environmental or occu-
pational factors may predispose to t he developtnent of acne or 
exacerbate the disease. Chronic exposure to cutting oils is well 
established as a causal factor, and epidemics of acne have been 
repor ted in workers exposed to halogenated hydrocarbons, such 
as halowax and pesticides. 
Recently, increasing attention has been focused on more 
common environmental and physical factors that may aggra-
vate t he disease: t he long-term use of occlusive cosmetics (acne 
cosmetica), overuse of abrasive soaps and cleansers (acne de-
tergicans) , and repeated friction in areas, such as beneath 
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shoulder pads and chin straps (acne mechanical . All appear to 
affect the follicle primarily; pathogenic mechanisms have not 
yet been studied. 
Animal Models 
Acne is a disease that uniquely affects man. The lack of an 
exact duplicate in the animal kingdom has seriously hindered 
research progress. Nevertheless, certain useful information has 
been derived from animal studies. 
The rabbit ear has proven to be a useful model for the study 
of comedo formation. Although morphologically, the pathologic 
dynamics of comedo formation in the rabbit and human appear 
to be similar, further examination and comparison are neces-
sary. The rabbit comedones are not colonized by P. acnes and 
do not progress to inflammatory lesions. Since P. acnes appears 
to use glycerol from triglycerides as a source of sugar, the 
absence of triglycerides in rabbit sebum may explain this lack 
of follicular colonization by P. acnes and is suggestive of the 
role of this organism in the inflammatvry reaction of acne. 
A wide variety of chemicals will rapidly induce comedones 
when applied to the external ear of the rabbit. The rabbit ear 
is far more sensitive than the follicle of man. Thus, potent 
comedogens, such as halogenated hydrocarbons, have been 
easily identified as comedogenic agents in both rabbit and man, 
whereas comedogens that may be potent for the rabbit but not 
for man are more difficult to assess in man. Although other 
animal models for comedogenicity such as the rhino mouse 
have proved of limited value, they merit further consideration. 
Sebaceous glands in mammals have been used extensively in 
the study of lipogenesis and the hormonal control of sebaceous 
glands. In particular, specialized sebaceous structures, such as 
the rat and mouse preputial gland and the costovertebral flank 
organ of the hamster, have been studied. The most extensive 
studies of the horrponal control of sebaceous glands have been 
on sebum production in the rat. Unfortunately, this model is of 
limited usefulness. Apparently, there are major differences in 
the hormonal control of rat and human sebaceous glands. For 
example, whereas progesterone stimulates rat sebaceous glands, 
there is no evidence for a similar effect in man. As another 
example, extensive studies in rats indicate the MSH, prolactin, 
somatrotrophin, ACTH, and TSH directly or indirectly affect 
the rate of sebum production. Since most of these experiments 
have been carried out in hypophysectomized animals it is 
difficult to assess their relevance to humans. Several patients 
with panhypopituitarism have been observed to produce sebum 
at a less than normal rate. On the other hand, study of sexual, 
ateliotic dwarfs revealed normal rates of sebum production, 
which suggests that growth hormone does not affect sebaceous 
glands in the human as it does those in the rat. 
Animal models appear to be most appropriate for the screen-
ing of antiandrogens and the assay of steroid hormone receptors. 
In this regard the hamster flank organ has been a very useful 
tool. DHT receptor protein was frrst demonstrated and the 
receptor sites characterized in this organ. Cyproterone acetate 
(CPA) has received extensive screening in animal models. These 
studies have demonstrated that CPA possesses antiandrogenic 
activity by competing with androgen for receptor sites. Subse-
quently, CPA and estrogens have been used successfully in 
Europe in the treatment of acne and hirsutism. Numerous other 
antiandrogens are being screened with these animal models. 
Sebaceous gland size is markedly decreased in the hamster 
flank organs during the administration of 13-cis retinoic acid 
without affecting the pigment cells or hair follicles. Thus it 
might be possible to decrease sebaceous secretion through 
selective posttranscriptional inhibition of the proliferating, ger-
minative sebocyte. 
Studies of lipid synthesis in mammalian sebaceous glands 
and specialized sebaceous structures have provided consider-
able insight into cutaneous lipogenesis. However, the sometimes 
striking differences between animal and human sebum cast 
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serious doubt upon the relevance of these studies to human 
disease in general and acne in particular. Nevertheless, the 
detailed study of lipogenesis in animal sebaceous glands has 
facilitated subsequent studies in man. 
Human Assessment 
The bulk of our knowledge concerning the hormonal control 
of human sebaceous glands derives from measurement of sebum 
production in man by the gravimetric technique. Although 
cumbersome and time consuming, this clinical research has 
clearly demonstrated the highly sensitive responsiveness of 
human sebaceous glands to androgens, their inhibition by es-
trogen as well as their responsiveness to a variety of other 
steroid and peptide hormones described previously. Sebum 
production studies in acne are of particular interest. These 
studies have revealed that, in general, the rate of sebum pro-
duction is higher in acne patients than in normal controls and 
that this rate tends to increase with the severity of the disease. 
There is, however, considerable individual variability, and some 
patients with severe acne have sebum production rates as low 
as those of normal controls. These observations have stimulated 
more intensive study of other pathogenic factors in acne. 
The use of thin-layer chromatography and photodensitome-
try in the analysis of human skin surface lipids has greatly 
advanced the study of human sebum composition. Studies in 
which these techniques were used have demonstrated that 
there are regional differences in skin surface lipid composition 
that are directly related to the regional density of sebaceous 
glands. Analysis of sebum composition has proved useful in 
determining the effect of antibiotics on the microbial flora since 
the concentration of free fatty acid in lipid on the skin surface 
appears to be related to the density of P. acnes in the follicle. 
More recently, analysis of sebum composition has been used as 
an indirect measure of sebum production. Since wax esters and 
squalene are derived from the sebaceous glands, alterations in 
sebum production is reflected in the relationship of the concen-
tration of these lipids to the concentration of sterols and sterol 
esters. This method has been employed in the study of the 
effects of 13-cis retinoic acid on sebum production. It offers 
promise as a useful screening method for other drugs that may 
affect sebum production. 
Quantitative assays of the follicular micro flora have helped 
to make clear the role of these microorganisms in the patho-
genesis of acne. These have proved particularly useful in the 
study of antimicrobial therapy in acne and they have provided 
a likely explanation for the lack of clinical efficacy of those 
antibiotics to which follicular microflora are, nonetheless, sen-
sitive in vitro. Thus, the tetracyclines and erythromycins, which 
are clinically effective in the treatment of acne, significantly 
reduce the follicular concentration of P. acnes. The penicillins, 
on the other hand, which are not useful clinically, do not 
effectively decrease the population of P. acnes despite marked 
in vitro sensitivity to these drugs. This suggests a relatively 
. poor follicular concentration of the penicillins. 
Currently used assays are less useful in the evaluation of 
topical antimicrobial therapy, except in a negative way. The 
scrub technique employed for the quantitative assay of the 
follicular microflora samples only the upper infundibular por-
tion of the follicle. Thus, dramatic decreases in P. acnes have 
been observed with topical antibacterials that have a less pro-
nounced clinical effect than systemic antibiotics. On the other 
hand, topical antibacterial agents that have little or no effect 
upon P. acnes density have proved to be clinically ineffective. 
The lack of suitable animal models has led to the develop-
ment of a human assay for the effects of drugs on comedones. 
First, small comedones are induced on the backs of human 
volunteers with coal tar or other comedogenic agents. These 
comedones are then examined by a noninvasive technique, viz. , 
their removal by means of cyanoacrylate adhesive. Recent 
experiments with this technique have confrrmed the clinical 
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efficacy of drugs such as tretinoin and salicylic acid in reducing 
comedones. This noninvasive technique offers promise in the 
screening of other "comedolytic" agents. 
As noted earlier, P. acnes produces significant quantities of 
porphyrins, which are fluorescent compounds. One can estimate 
the density of P. acnes in acne patients by examining the skin 
under a Wood's light. This is a useful, qualitative tool for 
evaluation of antimicrobial therapy in clinics where quantita-
tive microbiology is unavailable. Tetracycline is also a fluores-
cent compound that yields a bright yellow-green color under 
Wood's light examination in contrast to the coral pink fluores-
cence of porphyrins. Although this property of the drug is 
sometimes useful in assessing patient compliance with tetracy-
cline therapy, it is of limited value otherwise. 
Clinical change in acne is currently assessed principally by 2 
techniques: lesion counting and global assessment (acne grad-
ing). Lesion counting appears to be the more accurate method. 
It generally provides data more suitable for statistical analysis 
and is sensitive to smaller variations in the disease. Lesion 
counting, however, requires greater experience than global as-
sessment in recognizing types of lesions. It is certainly more 
time consuming. It is also limited in that the accuracy of data 
cannot be verified by examination of photographs. Lesion 
counting involves a separation of the clinical disease into its 
components, namely, open and closed comedones, papules, 
pustules, and nodules. Each type of lesion is recorded separately 
at each examination. Greatest accuracy is probably achieved by 
counting each of the lesions in one given area at a time, such as 
the forehead, chin, left cheek, and right cheek. These data are 
then analyzed with simple statistical methods. In general, ex-
cellent correlation has been found of the efficacy of drugs 
evaluated by lesion counting with the subsequent clinical ex-
perience of large numbers of physicians. 
Global evaluation involves an overall assessment of the se-
verity of the disease on some sort of grading scale such as 1 to 
10, 1 to 8, etc. This requires some form of agreement among 
investigators as to what constitutes degrees of severity. One 
system employs a series of photographs as a reference standard. 
When photographs are also taken of the study patients, the 
method offers the advantage of permitting data verification by 
others. 
Therapy for Acnes 
Two drugs, tretinoin and salicylic acid, have comedolytic 
activity; that is, they reduce the number of comedones. Treti-
noin (Vitamin A acid, retinoic acid) has been studied exten-
sively. Most studies report that this substance reduces the 
number of comedones by more than 50%. Tretinoin is also 
clinically effective in inflammatory acne, particularly when 
combined with systemic or topical antimicrobial therapy; pre-
sumably this beneficial effect results from the prevention of 
comedone formation. There is increased turnover of follicular 
epithelial cells and an apparent decrease in the cohesiveness of 
these cells when they are shed into the follicular lumen. Unfor-
tunately, tretinoin frequently produces erythema and some 
degree of desquamation, side effects that are, at the least, 
unpleasant and sometimes result in the discontinuance of its 
use. There is often a transient flare of inflammatory lesions in 
the early stages of therapy with this drug and an increased 
susceptibility to sunburn. Only if the physician takes the time 
to educate the patient can the tretinoin therapy be successful. 
Salicylic acid is also effective in reducing comedones. How-
ever, concentrations that have a comedolytic effect equal to 
that of tretinoin produce a marked and decidedly unpleasant 
exfoliation of the skin. Some experiments indicate that salicylic 
acid exerts its effect by hydrolyzing intercellular cement sub-
stance. Other studies suggest that salicylic acid may possess the 
anti-inflammatory properties of other salicylates and may be 
useful in inflammatory acne. 
Systemic and topical antimicrobial therapy has proved useful 
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in the treatment of inflammatory acne. Tetracyclines and eryth-
romycin, administered systemically, produce a significant re-
duction in P. acne.') and a concomitant clinical improvement in 
acne. Doses as low as 250 to 500 mg daily can suppress the 
disease. Continued administration is required for control. Doses 
as high as 3 gm per day are sometimes necessary in the 
treatment of severe inflammatory acne. Although these antibi-
otics have a high degree of safety in long-term use, they may be 
associated with vaginal moniliasis and a variety of minor gas-
trointestinal disturbances. Tetracyclines, but not erythromycin, 
are associated with photosensitivity reactions. Recent experi-
ments suggest that these antibiotics inhibit neutrophil chemo-
taxis and may, therefore, possess anti-inflammatory properties 
as well. 
Benzoyl peroxide in 5% and 10% concentrations effectively 
reduces P. acnes when applied to the skin. It is usually less 
effective than systemic antibiotics; its efficacy appears to in-
crease when used with tretinoin. Mild local initation and des-
quamation are frequent side effects. Rarely, allergic contact 
dermatitis develops, in which case further use is precluded. 
Recent experiments with topical antibiotics (erythromycin, 
clindamycin, and tetracycline) suggest that this route of anti-
biotic delivery is also helpful in treating inflammatory acne. 
Their efficacy, however, does not appear to be greater than that 
of benzoyl peroxide and is probably not equal to adequate doses 
of systemic antibiotics. Increase in drug concentration and 
improvement in the vehicle composition may yield more effec-
tive topical antibiotic therapy in the future. 
Sebum production can be suppressed effectively through the 
systemic administration of estrogen-containing compounds, 
such as oral contraceptives. There is usually a concomitant 
improvement in acne. Maximal reduction in sebum production 
is achieved with the administration of ethinyl estradiol or 
mestranol in doses of 100 mcg; concentrations as low as 50 mcg 
may be suppressive in some patients. This reduction in sebum 
may be partially inhibited by the concomitant administr~tion 
of weakly androgenic progrestational agents, such as norgestrel. 
Despite their beneficial effect in acne, estrogens are oflimited 
usefulness in the treatment of the disease. For obvious reasons 
they cannot be administered to men and should not be admin-
istered to girls before closure of the epiphyses of the long bones. 
Therapy for 3 months or longer may be required before a 
sign ificant clinical effect is discernible. The use of estrogens, 
particularly with high dose formulations, increases the risk of 
developing thromboembolic phenomena. 
Orally administered 13-cis retinoic acid, shown to reduce 
selectively the size of sebaceous glands in hamster flank organs, 
has recently been reported to effect dramatic improvements in 
patients with acne. Studies now in progress indicate that this 
drug may decrease sebum production in man. 
There al·e several other treatments for acne. Severe nodulo-
cystic and conglobated acne may, on occasion, respond to 
treatment with sulfones. Doses of 100 to 200 mg per day are 
usually required. The mechanism of action of sulfones is poorly 
understood; however, they have been shown to inhibit potas-
sium iodide pustule formation in skin. These drugs produce 
methemoglobinemia, anemia and rarely a peripheral motor 
neUTopathy. Their use is contraindicated in patients with glu-
cose-6-phosphate dehydrogenase deficiency. 
Glucocorticosteroids are also useful in the treatment of severe 
inflammatory acne. The anti-inflammatory properties of this 
class of compounds is well established. However, serious side 
effects such as Cushing's syndrome, diabetes, superinfection, 
and osteoporosis preclude their long-term use in acne. 
Intralesional injection of triamcinolone acetonide or hexace-
tonide, 2-5 mg per mI, is the preferred method for the admin-
istration of these steroids in acne; systemic effects are mini-
mized because the total amount of steroid is small and the 
absorption into the bloodstream is slow. Although this treat-
ment provides rapid involution of inflammatory lesions, nodu-
locystic lesions tend to reCUT. 
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Cryosurgery with liquid nitrogen or solid carbon dioxide also 
resolves inflammatory lesions, usually for a . longer period of 
time than is attained by the intralesional injection of steroids. 
Initial application, however, is painful and the subsequent 
edematous reaction produces a temporary flareup of the treated 
lesion. 
Topical preparations containing varying concentrations of 
resorcin and sulfur are of some use in acne treatment. Although 
these compounds can accelerate the resolution of small inflam-
matory lesions, they have little effect on the overall course of 
the disease. Their mechanism of action is not understood. 
Comedo extraction is of temporary benefit. It does not appear 
to alter the course of the disease appreciably since comedones 
reform quite rapidly. The procedure is frequently, however, of 
considerable subjective benefit to the patient. Drainage of 
superficial pustules is often beneficial. 
NEEDS FOR ADDITIONAL RESEARCH 
Studies on the Differentiation of Follicular Epithelium 
Differentiation of follicular epithelium is a new area for basic 
research despite the evidence for abnormal keratinization in 
the acne follicle. 
1. Although acne occurs only in humans, development of 
animal models for studies of the follicle should be encouraged. 
2. Both animal and human models should be employed to 
investigate induction of follicular dyskeratoses by physical and 
chemical factors, kinetics of follicular epithelium, and comedo 
formation. The technology available for investigations of kera-
tin, lipids, and lamellar granules should be applied to the hair 
follicle . . 
3. The permeability of the follicle to simple and complex 
chemicals and the migration of cells across the follicle wall may 
be important factors in both pathogenesis and the effectiveness 
of drugs and need to be investigated. 
Hormonal Control of Sebaceous Glands 
Our understanding of hormonal control of sebaceous glands 
Ihas progressed to the point where we can emphasize studies at 
the cellular level. 
1. Studies are needed to further characterize steroid recep-
tors and the effect of steroid-receptor complexes on the kinetics 
and lipid metabolism of the sebaceous gland cell. 
2. Metabolic pathways for steroid hormones within seba-
ceous glands, follicular epithelium, and surrounding dermis 
need to be defined. Microbial transformations of steroid and 
steroid-like hormones in the follicle merit further study. 
3. Interrelated effects of steroids and nonsteroidal hormones 
on the pilosebaceous organ require further study. Data available 
from animal models need to be validated in primates (including 
humans). 
4. Continuing study of how antiandrogens interfere with 
specific reactions in hormonal metabolism should lead to a 
better understanding of ways in which sebaceous proliferation 
and sebum production could be inhibited. The ultimate goal is 
to define an antiandrogen or a route of delivery that affects 
only sebaceous glands. 
Microbiology of the Follicle 
There is increasing evidence that P. acnes is important in 
the pathogenesis of acne and this relationship needs to be 
defined. 
1. F urther characterization of this organism including kary-
otyping and gas chromatographic analysis of cell wall lipids is 
in order. The relationship of P. acnes to other propionibacteria 
and corynebacteria, particularly C. parvum, should be ascer-
tained. 
2. The exoenzymes of P. acnes should be characterized and 
the antigenic fu nction of the organism and its products defined. 
3. The interaction of P. acnes and other follicular organisms, 
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such as coagulase negative staphylococci and the Pityrosporurn 
species, in the inflammatory process of acne needs further 
study. 
Inflammation and Immunology 
Investigation of the inflammatory components and the role 
of immune mechanisms of acne is at a rudimentary level. It is 
already apparent, however, that further exploration of these 
areas will provide better insights into pathogenesis and, ulti-
mately, to treatment modalities. Available technology needs to 
be applied. 
1. The inflammatory response must be defined in terms of 
chemotaxis, cell mediated immunity, the role of complement 
activator, and immune complexes. 
2. The role of cytotaxis, inflammatory mediators, and anti-
gens originating in the follicle need to be discovered. 
3. The nature of the tissue injury that results in atrophic and 
hypertrophic scarring should be explored. 
Lipid Metabolism in Sebaceous Glands 
1. A more detailed characterization of the pathways for syn-
thesis in sebaceous glands is required. Unless an animal model 
for acne can be developed, this information will have to come 
from the study of human sebaceous glands. 
2. Since skin surface lipid from some acne patients is deficient 
in linoleic acid, it is to the point to study the metabolic pathway 
for linoleic acid synthesis. The pathways of arachidonic acid 
and 'prostaglandin synthesis in sebaceous glands must be clari-
fied in light of their potential role in inflammatory acne. 
3. Methods must be found to study how dietary lipids affect 
lipogenesis in individual sebaceous glands; present methods 
cannot be applied to the study of individual glands. 
4. Support should be given to studies for developing in vitro 
systems in which explants of human skin rich in sebaceous 
glands are used. This would permit more rapid advances in our 
understanding of sebaceous gland lipogenesis. 
NEEDS FOR ADDITIONAL CLINICAL RESEARCH 
Patterns of Disease 
Adequate baseline data on acne are not available; these data 
are necessary for objective evaluation of various therapeutic 
agents and to complete our understanding of biological and 
environmental factors that alter susceptibility to the disease 
and the course of existing disease. An immediate need is a 
reevaluation of current methods for measurement of clinical 
changes. Systems to measure acne must be devised that will 
permit direct comparison of data from different investigative 
groups. The natural history of the disease must be categorized 
by age and sex. Skin type, variations during the menstrual 
cycle, dietary factors, including trace metals, all need to be 
taken into account. Then the following kinds of problems can 
be undertaken. 
1. Acne is usually a self-limiting disease but we do not know 
why. Long-term observation of all the variables appearing to 
influence lj,cne may help us understand why the disease even-
tually disappears. It might then be possible to intervene earlier 
in the disease process to hasten this disappearance. 
2. Stress is a suspected but unproven pathogenic factor in 
acne. Controlled studies should be carried out to determine the 
influence of stress upon the severity of disease. 
3. It is unclear whether early treatment modifies the severity 
of the disease or reduces its sequelae. Carefully collected data 
systematically obtained from different centers throughout the 
country should help to answer this question. 
4. There are now drugs available that work upon specific 
pathogenic factors in acne. These drugs should be used as tools 
in order to determine what events ensue upon the alteration of 
a single factor in the pathogenic process. 
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Keratinization and Comedogenesis 
We do not fully understand what factors affect epithelial 
differentiation within the follicle nor do we know how the 
comedo is formed. Comparative studies are urgently needed in 
severe destructive inflammatory acne and in comedonal acne. 
These data need to be compared with data on follicles no longer 
involved in the acne process. Persons with drug-induced acne 
would be suitable models for studies on cell kinetics, resolution 
of comedones, and structural changes within the follicle. 
Sebum Production and Composition 
Present methods for measuring sebum production are diffi-
cult and time-consuming. A simple and more accurate method 
to measure sebum production would facilitate clinical screening 
of drugs and make possible an evaluation of the effect of 
additional hormonal and nutritional factors on the sebaceous 
gland. Analysis of lipid samples from individual follicles is also 
• desirable. 
Clinical Microbiology 
Present microbiological sampling methods allow examination 
of only the superficial portions of the follicle. We need to 
develop new methods for microbiological sampling deeper 
within the follicle. 
Clinical Immunology 
We need to find out if specific defects in immune responses 
contribute to the more severe inflammatory forms of acne; for 
example, why do patients with conglobate acne have a de-
creased reactivity to intradermally injected antigens? In these 
patients we should study responses of the immune systems, 
neutrophils, and lymphocytes to bacterial antigens and to sim-
ple irritants. The goal of such research is to develop methods 
that would identify those patients who will eventually progress 
to severe inflammatory acne. This done, it might be possible to 
ameliorate the severity of the inflammatory process by correct-
ing specific immunologic defects. 
Therapy 
High priority must be given to the development of new and 
improved topical therapy for acne. There is obvious logic in 
direct delivery of drugs to the target organ as it reduces the risk 
of systemic side effects. Innovative vehicle design should sig-
nificantly improve the delivery of currently available drugs and 
encourage the development of new drugs. A description of the 
, needs for specific kinds of therapeutic agents follows. 
1. We do not know the mechanism of action of comedolytic 
agents, such as tretinoin and salicylic acid. Clarification oftheir 
action could stimulate the development of new drugs that could 
be more effective and have fewer unpleasant side effects. The 
retinoids are examples of drugs that should be studied inten-
sively. 
2. Some topical antibacterial agents, such as benzoyl perox-
ide, have proved to be useful in acne therapy. However, a large 
number of potentially effective surface-active antibacterial 
agents are not effective. Perhaps research to improve delivery 
systeITls of these antibacterial agents would improve their ac-
tion. 
3. There are some drugs that appear to interfere with lipid 
synthesis and decrease sebum production. These drugs have 
unpleasant side effects that preclude their routine use. There is 
a need to develop new drugs, including antiandrogens, that will 
be effective when applied topically. Locally active compounds 
that can alter the pathways of lipid synthesis within the seba-
ceous gland must be discovered. 
T he recent finding that the oral administration of l3-cis 
retinoic acid produces a marked decrease in sebum production 
as well as improvement in patients with severe nodulocystic 
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acne provides a challenging avenue for new research. Further 
investigation of the mechanism of action of this drug and 
related compounds could result in a better understanding of the 
control of sebaceous gland function as well as improved treat-
ment for acne. 
4. Systemic and topical corticosteroids are of limited useful-
ness in the treatment of acne because of their adverse side 
effects. A search should be made for nonsteroidal anti-inflam-
matory agents, particularly those that can be applied topically. 
Explorations should continue on the anti-inflammatory prop-
erties of topically-applied antibiotics, such as tetracycline and 
erythromycin, in an attempt to clarify their mechanism of 
action. 
5. Ultraviolet light has been a popular acne treatment. There 
is doubt of its usefulness. A definitive answer should be obtained 
on the value of this therapy. 
6. As the pathogenic role of microbial exoenzymes becomes 
clearer, a systematic search of specific enzyme inhibitors should 
be made. Such enzyme inhibitors could be used both as tools 
for furthering our understanding of the pathogenic process and 
as therapeutic agents for treating acne. 
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